Top Pharmaceuticals companies in Hong Kong by Revenue
Hong Kong
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 34.62 B
|
Dec. 31, 2023 | USD 0.67 | 1.53% |
|
Hong Kong |
|
| 2 |
USD 3.74 B
|
March 31, 2024 | USD 0.43 | 2.74% |
|
Hong Kong |
|
| 3 |
USD 3.69 B
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
|
| 4 |
USD 2.55 B
|
Dec. 31, 2023 | USD 0.26 | 1.45% |
|
Hong Kong |
|
| 5 |
USD 2.46 B
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
|
| 6 |
USD 1.94 B
|
Dec. 31, 2023 | USD 1.42 | 0.70% |
|
Hong Kong |
|
| 7 |
USD 1.13 B
|
Dec. 31, 2023 | USD 0.91 | -0.72% |
|
Hong Kong |
|
| 8 |
USD 838.00 M
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
| 9 |
USD 827.46 M
|
Dec. 31, 2023 | USD 0.41 | 1.55% |
|
Hong Kong |
|
| 10 |
USD 518.60 M
|
Dec. 31, 2023 | USD 0.49 | 2.14% |
|
Hong Kong |
|
| 11 |
USD 259.86 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
| 12 |
USD 246.33 M
|
Dec. 31, 2023 | USD 0.25 | 3.70% |
|
Hong Kong |
|
| 13 |
USD 195.24 M
|
Dec. 31, 2023 | USD 1.04 | 1.48% |
|
Hong Kong |
|
| 14 |
USD 187.51 M
|
March 31, 2024 | USD 0.13 | 1.98% |
|
Hong Kong |
|
| 15 |
USD 178.00 M
|
March 31, 2024 | USD 0.27 | 0.92% |
|
Hong Kong |
|
| 16 |
USD 173.98 M
|
Dec. 31, 2023 | USD 0.21 | 10.11% |
|
Hong Kong |
|
| 17 |
USD 162.14 M
|
Dec. 31, 2023 | USD 0.15 | -0.02% |
|
Hong Kong |
|
| 18 |
USD 155.56 M
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
| 19 |
USD 153.87 M
|
Dec. 31, 2023 | USD 0.47 | -0.57% |
|
Hong Kong |
|
| 20 |
USD 153.46 M
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
| 21 |
USD 134.82 M
|
Dec. 31, 2023 | USD 0.16 | -0.02% |
|
Hong Kong |
|
| 22 |
USD 118.53 M
|
Dec. 31, 2023 | USD 0.18 | -0.02% |
|
Hong Kong |
|
| 23 |
USD 82.84 M
|
March 31, 2024 | USD 0.22 | -1.75% |
|
Hong Kong |
|
| 24 |
USD 43.77 M
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
| 25 |
USD 33.20 M
|
Dec. 31, 2023 | USD 0.31 | 0.39% |
|
Hong Kong |
|
| 26 |
USD 21.74 M
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
| 27 |
USD 397.00 K
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
|
| 28 |
USD 192.26 K
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
| 29 |
USD 0.00
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
Frequently Asked Questions
-
Which Pharmaceuticals company in Hong Kong has the highest Revenue ?
The Pharmaceuticals company in Hong Kong with the highest Revenue is China Resources Pharmaceutical Group Limited (HKSE: 3320.HK) at USD 34.62 B.
-
Which Pharmaceuticals company in Hong Kong has the lowest Revenue ?
The Pharmaceuticals company in Hong Kong with the lowest Revenue is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 0.00.
-
What are the top 10 Pharmaceuticals companies in Hong Kong by Revenue ?
The top 10 Pharmaceuticals companies in Hong Kong by Revenue are China Resources Pharmaceutical Group Limited, Alibaba Health Information Technology Limited, Sino Biopharmaceutical Limited, China Traditional Chinese Medicine Holdings Co. Limited, BeiGene, Ltd., The United Laboratories International Holdings Limited, China Medical System Holdings Limited, HUTCHMED (China) Limited, SSY Group Limited and Lee & Man Chemical Company Limited.
-
What are the bottom 10 Pharmaceuticals companies in Hong Kong by Revenue ?
The bottom 10 Pharmaceuticals companies in Hong Kong by Revenue are Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Sirnaomics Ltd., Prenetics Global Limited, Pak Fah Yeow International Limited, Yunnan Energy International Co. Limited, JBM (Healthcare) Limited, Jilin Province Huinan Changlong Bio-pharmacy Company Limited, Lee's Pharmaceutical Holdings Limited and Tycoon Group Holdings Limited.